SEC Form 4 · accession 0001630998-16-000011
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gibertini
Officer — President Clinical Development
Period of report
Jun 6, 2016
Accepted (ET)
Jun 7, 2016 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 6, 2016 | M | 153,716 | $8.45 | A | 200,998 | D | |
| Class A Common StockF2 | Jun 6, 2016 | S | 144,682 | $43.0528 | D | 56,316 | D | |
| Class A Common StockF3 | Jun 6, 2016 | S | 9,034 | $43.8318 | D | 47,282 | D | |
| Class A Common Stock | Jun 6, 2016 | M | 14,628 | $10.57 | A | 61,910 | D | |
| Class A Common StockF4 | Jun 6, 2016 | S | 13,751 | $43.1851 | D | 48,159 | D | |
| Class A Common StockF5 | Jun 6, 2016 | S | 877 | $43.816 | D | 47,282 | D | |
| Class A Common Stock | Jun 6, 2016 | M | 17,752 | $16.06 | A | 65,034 | D | |
| Class A Common StockF6 | Jun 6, 2016 | S | 16,652 | $43.0494 | D | 48,382 | D | |
| Class A Common StockF7 | Jun 6, 2016 | S | 1,100 | $43.7566 | D | 47,282 | D | |
| Class A Common StockF2 | Jun 6, 2016 | S | 26,394 | $43.05 | D | 20,888 | D | |
| Class A Common StockF8 | Jun 6, 2016 | S | 1,476 | $43.843 | D | 19,412 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F9 | $8.45 | Jun 6, 2016 | M | 153,716 | D | — | Sep 28, 2020 | Class A Common Stock | 153,716 | 51,928 | D |
| Stock Option (Right to Buy Class A Common Stock)F10 | $10.57 | Jun 6, 2016 | M | 14,628 | D | — | Aug 17, 2022 | Class A Common Stock | 14,628 | 9,750 | D |
| Stock Option (Right to Buy Class A Common Stock)F11 | $16.06 | Jun 6, 2016 | M | 17,752 | D | — | Jun 30, 2024 | Class A Common Stock | 17,752 | 41,419 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2016.
- F10One half of the shares subject to this option vest yearly in five equal installments beginning on August 17, 2013, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.
- F11One half of the shares subject to this option vest yearly in five equal installments beginning on June 30, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.
- F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.69 to $43.68, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.69 to $44.18, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.70 to $43.68, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.71 to $43.95, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F6The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.68 to $43.67, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F7The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.68 to $43.96, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F8The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.69 to $44.23, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F9One half of the shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.